PUBLISHER: DataM Intelligence | PRODUCT CODE: 1629898
PUBLISHER: DataM Intelligence | PRODUCT CODE: 1629898
The Asia-Pacific advanced wound care market reached US$ 2.2 billion in 2024 and is expected to reach US$ 3.4 billion by 2033, growing at a CAGR of 5.1% during the forecast period 2025-2033.
Advanced wound care refers to specialized medical treatments, products and technologies designed to manage complex, non-healing, or chronic wounds that require more than basic wound care methods. These wounds may include diabetic foot ulcers, venous leg ulcers, pressure ulcers, surgical wounds, traumatic injuries, and burns. Unlike traditional wound care, which primarily focuses on cleaning and protecting wounds with simple dressings, advanced wound care involves the use of scientifically developed solutions that promote faster healing, manage infections, reduce pain, and improve the overall quality of life for patients.
The Asia-Pacific advanced wound care market is experiencing significant growth, driven by factors such as the increasing prevalence of chronic diseases, technological advancements and rising awareness and wound care initiatives in the region. For instance, in September 2024, HCAH, a leading provider of comprehensive out-of-hospital healthcare solutions in India, introduced a groundbreaking initiative aimed at accelerating patient recovery and improving healing processes. The company partnered with Aroa Biosurgery of New Zealand to tackle the challenges associated with bedsores and enhance patient care. With this partnership, HCAH launched the "WOW (Warriors of Woundcare) Nurses" programme, which focuses on preventing and treating bedsores effectively.
Market Dynamics: Drivers & Restraints
Rising aging population and prevalence of chronic diseases
The rising aging population and prevalence of chronic diseases are significantly driving the growth of the advanced wound care market in Asia-Pacific and are expected to drive the market over the forecast period. As people age, they are more susceptible to conditions that require advanced wound care, such as pressure ulcers due to prolonged immobility, diabetic foot ulcers due to complications from diabetes, and venous leg ulcers from poor circulation. Countries like Japan reported significant increases in the number of elderly patients requiring advanced wound management solutions.
For instance, according to the study conducted by the National Institute of Health, Of the 1126 participants, 113 (10%) had one or more pressure injuries. Overall, the estimated number of adults with pressure injuries in Goto (a city located on a remote rural archipelago in Japan) was 301.4. The prevalence rate of pressure injuries was 9.2 per 1000 population in adults aged >=18 years, 20.3 in those aged >=65 years, and 44.6 in those aged >=80 years.
The high prevalence of diabetes across Asia, especially in countries like India and China, contributes significantly to the demand for advanced wound care. Chronic diabetic wounds, such as diabetic foot ulcers, are a major concern as they can lead to severe complications like amputations if not treated properly.
For instance, according to the World Health Organization, in India, an estimated 77 million people above the age of 18 years are suffering from diabetes (type 2) and nearly 25 million are prediabetics (at a higher risk of developing diabetes in the near future). More than 50% of people are unaware of their diabetic status. These lead to an increased need for advanced wound care products, such as advanced dressings and therapy devices, to manage chronic wounds effectively.
As the demand for effective wound management solutions grows, there is increased adoption of advanced wound care technologies, including bioengineered skin substitutes, negative pressure wound therapy (NPWT), and advanced dressings, which are becoming essential in treating these chronic wounds. For instance, in March 2022, Advanced Oxygen Therapy Inc. (AOTI) received the Chinese National Medical Products Administration (NMPA), commonly referred to as China FDA, approval for its unique cyclically pressurized Topical Wound Oxygen (TWO2) therapy.
Cultural and traditional preferences
Cultural and traditional preferences significantly hamper the growth of the Asia-Pacific advanced wound care market by influencing patients' and healthcare providers' choices in wound management. These cultural preferences often lead to the use of traditional methods over advanced, scientifically proven solutions.
In many Asian countries, there is a strong cultural inclination towards using herbal and natural remedies for health issues, including wound care. These treatments are perceived as more accessible, cost-effective, and culturally acceptable, often passed down through generations. For instance, in countries like India and China, traditional medicines, such as turmeric, neem, and aloe vera, are widely used to treat wounds due to their antiseptic and healing properties.
In rural areas of India, it's common for families to use turmeric paste or neem leaves to cover wounds, believing that these natural substances promote faster healing and prevent infections. This preference for home remedies or traditional methods over modern, scientifically backed wound care solutions hinders the adoption of advanced wound care products that could offer better outcomes.
Cultural resistance plays a significant role in the slow uptake of advanced wound care solutions. In some communities, there is skepticism about the safety and efficacy of new technologies due to concerns about side effects or unfamiliarity. Traditional methods, deeply rooted in local culture, are often trusted more because they are seen as safe and proven over generations.